Book Review: The Enemies of Rome: From Hannibal to Attila the Hun

Archives

by Philip Matyszak

New York: Thames & Hudson, 2005. Pp. 296. Illus., maps, biblio., index. $31.95. ISBN:0500287724

The Enemies of Rome is a survey of Roman history from its beginning through the mid-Fifth Century, told through the interactions between the Romans and some of their most notable enemies. 

Written for the non-specialist, the book is divided into four periods; the age of Republican expansion (c. 264-c. 100 B.C.), the civil wars (c. 100-30 B.C.), the Pax Romana (30 B.C.- A.D. 200), and the long decline (c. 200-c. 450). For each period, several notable foes of Rome are each covered by a chapter that discusses their background, the causes of conflict with Rome , their forces and skills, and the reasons for their success or failure, with some critical analysis. The leaders are a diverse group, some are national leaders, some "rebels" against established Roman rule, and, of course some are "Barbarians" -- Hannibal, Philip V of Macedon, Viriathus, Jugurtha, Mithradates of Pontus Spartacus, Vercingetorix, Orodes, Cleopatra, Arminius, Boudicca, Josephus, Decebalus, Shapur I, Zenobia, Alaric, and Attila. 

While the specialist might quibble about some of the coverage, or about what and who are not included (the era of the Kings and the Early Republic, as well as the Surena, Juba , Tacfarinas, the list is long), this is an excellent introduction for anyone lacking a serous background in Roman history.

Reviewer: A. A. Nofi   


Buy it at Amazon.com

X

ad

Help Keep Us From Drying Up

We need your help! Our subscription base has slowly been dwindling.

Each month we count on your contribute. You can support us in the following ways:

  1. Make sure you spread the word about us. Two ways to do that are to like us on Facebook and follow us on Twitter.
  2. Subscribe to our daily newsletter. We’ll send the news to your email box, and you don’t have to come to the site unless you want to read columns or see photos.
  3. You can contribute to the health of StrategyPage.
Subscribe   contribute   Close